Portal de Periódicos da CAPES

Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment

2004; Elsevier BV; Volume: 58; Issue: 3 Linguagem: Inglês

10.1016/j.ijrobp.2003.06.001

1879-355X

Raymond Miralbell, Gemma Sancho, Sabine Bieri, Ignasi Carrió, Claudine Helg, Salut Brunet, Pierre‐Yves Martin, Anna Sureda, G. Gómez de Segura, B Chapuis, Montserrat Estorch, Mahmut Özsahin, Alain Keller,

Dialysis and Renal Disease Management

Purpose Patients with malignant hematologic disorders undergoing bone marrow transplantation (BMT) may develop renal insufficiency. A study was undertaken to assess prospectively the subclinical renal function changes with radioisotopic methods in patients undergoing BMT for hematologic malignancies. Methods and materials We studied 71 patients with normal renal function undergoing BMT for various hematologic malignancies, mostly leukemias. Conditioning included chemotherapy and 12 Gy (45 patients) or 13.5 Gy (26 patients) fractionated total-body irradiation (TBI). In 21 patients receiving 12 Gy TBI, the kidney dose was limited to 10 Gy using partial transmission blocks fabricated after renal opacification with nonionic, hypo-osmolar contrast medium. The glomerular filtration rate (GFR) and effective renal plasmatic flow (ERPF) were determined radioisotopically before conditioning and at 4, 12, and 18 months, using 51Cr ethylene-diamine-tetra-acetic acid and 131I ortho-iodo-hippurate, respectively. Renal insufficiency was defined as a decrease of ≥30% in GFR or ERPF compared with the baseline values. The potential influence of patient- and treatment-related variables on renal dysfunction was assessed. Results At 4 (early) and 12–18 (late) months, a ≥30% GFR drop was observed in 54% and 49% of patients and a ≥30% ERPF drop in 44% and 34% of patients, respectively. After stepwise logistic analysis, a GFR reduction at 4 months correlated significantly with age (<40 years old, worse), TBI using kidney blocks (partial kidney shielding to 10 Gy was associated with a higher rate of renal dysfunction at 4 months compared with the full TBI dose), and days of aminoglycoside/vancomycin use. An ERPF drop at 4 months was independently related with the days of amphotericin use and days of prostaglandin E1 use (prophylaxis against hepatic venoocclusive disease). A GFR and ERPF reduction at 12–18 months correlated with days of amphotericin use and days of prostaglandin E1 use, respectively. Conclusion Early post-BMT renal dysfunction is associated with the administration of potentially nephrotoxic drugs. An inverse correlation with the prescribed TBI dose was observed; patients whose kidneys received 10 Gy through the use of partial shielding blocks had significantly greater renal dysfunction at 4 months. The administration of potentially nephrotoxic contrast agents used in radiotherapy treatment planning may be responsible for the latter observation. Prostaglandin E1 use correlated with a significant reduction in ERPF at both 4 and 12–18 months.